Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Dermatology

Free Subscription Articles published in Am J Ophthalmol Retrieve available abstracts of 18 articles: HTML format

Single Articles

July 2025
1. CASTILLEJO BECERRA CM, Crowson CS, Langenfeld HE, Tajfirouz D, et al
   Population-Based Performance of Inflammatory Markers in Giant Cell Arteritis.
   Am J Ophthalmol. 2025;275:47-51.
   PubMed     Abstract available
   
   
   May 2025
2. CHOU HD, Heimann H, Damato BE, Hussain RN, et al
   Inadvertent Scleral Perforation During Choroidal Melanoma Surgeries: Incidence, Risk Factors, Management, and Outcomes: Scleral Perforation in Melanoma Surgery.
   Am J Ophthalmol. 2025 May 31:S0002-9394(25)00278.
   PubMed     Abstract available
   
   
   March 2025
3. MUKIT FA, Terfloth N, Kim IK, Wu F, et al
   Malignant transformation of ocular melanocytoma to uveal melanoma: a clinicopathologic review of three novel unsuspected cases of a likely under-recognized phenomenon, with review of the literature and molecular genetic data.
   Am J Ophthalmol. 2025 Mar 31:S0002-9394(25)00164.
   PubMed     Abstract available
   
   
   
4. WANG C, Gu J
   Giant Conjunctival Melanoma.
   Am J Ophthalmol. 2025 Mar 27:S0002-9394(25)00156.
   PubMed    
   
   
   
5. NISSEN K, Kiilgaard JF, Fili M, Seregard S, et al
   Increasing Incidence of Posterior Uveal Melanoma in Scandinavia 1960-2022: A Tri-National Study.
   Am J Ophthalmol. 2025 Mar 5:S0002-9394(25)00115.
   PubMed     Abstract available
   
   
   February 2025
6. JANMOHAMED IK, Salam MAU, Jamall O, Elgharably M, et al
   Faricimab-Associated Intraocular Inflammation with Features of Herpes Simplex Virus.
   Am J Ophthalmol. 2025 Feb 25:S0002-9394(25)00096.
   PubMed     Abstract available
   
   
   December 2024
7. CAPPELLI L, Khan MM, Shields CL, Lally SE, et al
   Favorable outcomes of patients with high-risk uveal melanoma treated with a novel LINAC-based frameless fractionated stereotactic radiosurgery.
   Am J Ophthalmol. 2024 Dec 18:S0002-9394(24)00564.
   PubMed     Abstract available
   
   
   October 2024
8. TIAN H, Shi H, Chen J, Zhu T, et al
   Circulating tumor DNA in conjunctival melanoma: landscape and surveillance value.
   Am J Ophthalmol. 2024 Oct 16:S0002-9394(24)00479.
   PubMed     Abstract available
   
   
   
9. LAI WY, Demer JL
   Cutaneous Lower Eyelid Retractor Release Averts Lower Lid Malposition After Inferior Rectus Muscle Recession.
   Am J Ophthalmol. 2024 Oct 9:S0002-9394(24)00460.
   PubMed     Abstract available
   
   
   
10. ZHANG MG, Gallo RA, Tan CH, Camacho M, et al
    Single-cell RNA profiling of ocular adnexal sebaceous carcinoma reveals a complex tumor microenvironment and identifies new biomarkers.
    Am J Ophthalmol. 2024 Oct 9:S0002-9394(24)00471.
    PubMed     Abstract available
    
    
    
11. BARBARA R, Abdelaal AM, Levy R, Nagy A, et al
    Pediatric Eyelid Cutaneous Horns: A Case Series and Literature Review.
    Am J Ophthalmol. 2024 Oct 9:S0002-9394(24)00465.
    PubMed     Abstract available
    
    
    September 2024
12. RAMING K, Pfau M, Herrmann P, Holz FG, et al
    Anti-VEGF Treatment for Secondary Neovascularization in Pseudoxanthoma Elasticum - Age of Onset, Treatment Frequency, and Visual Outcome.
    Am J Ophthalmol. 2024;265:127-136.
    PubMed     Abstract available
    
    
    August 2024
13. LEE MY, Han K, Min KH, Yu DS, et al
    Psoriasis as a Predictor of Neovascular Age-Related Macular Degeneration in Type 2 Diabetes Mellitus: A Nationwide Cohort Study.
    Am J Ophthalmol. 2024 Aug 30:S0002-9394(24)00395.
    PubMed     Abstract available
    
    
    
14. VEMPULURU VS, Tanna V, Luthra A, Kaliki S, et al
    Eyelid/Periocular Sebaceous Gland Carcinoma in 500 Eyes: Analysis based on 8(th) Edition American Joint Cancer Committee Classification.
    Am J Ophthalmol. 2024 Aug 3:S0002-9394(24)00350.
    PubMed     Abstract available
    
    
    July 2024
15. JUNG H, Kim S, Lee CS, Byeon SH, et al
    Real-world incidence of incident noninfectious uveitis in patients treated with BRAF inhibitors: a nationwide clinical cohort study.
    Am J Ophthalmol. 2024 Jul 6:S0002-9394(24)00300.
    PubMed     Abstract available
    
    
    May 2024
16. KOJIMA M, Mieno H, Ueta M, Nakata M, et al
    Improvement of the Ocular Prognosis of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A National Survey in Japan.
    Am J Ophthalmol. 2024 May 23:S0002-9394(24)00212.
    PubMed     Abstract available
    
    
    
17. WYLEGALA A, Pajak J, Wylegala E
    Bilateral Corneal and Conjunctival Melanosis.
    Am J Ophthalmol. 2024 May 17:S0002-9394(24)00206.
    PubMed    
    
    
    November 2023
18. CHOUDHRY HS, Patel AM, Nguyen HN, Kaleem MA, et al
    Significance of Social Determinants of Health in Tumor Presentation, Hospital Readmission, and Overall Survival in Ocular Oncology.
    Am J Ophthalmol. 2023 Nov 11:S0002-9394(23)00455.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Dermatology is free of charge.